Vaxart, Inc. VXRT
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 22.31% | 201.10% | 439.32% | 726.68% | 784.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.31% | 201.10% | 439.32% | 726.68% | 784.27% |
| Cost of Revenue | -26.77% | 55.89% | 132.99% | 171.62% | 170.25% |
| Gross Profit | 262.34% | 256.90% | 243.62% | 178.40% | 37.63% |
| SG&A Expenses | 11.24% | 6.42% | -7.67% | -15.26% | -19.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.30% | 49.34% | 107.96% | 130.74% | 122.75% |
| Operating Income | 161.71% | 171.37% | 166.80% | 127.26% | 31.88% |
| Income Before Tax | 159.04% | 169.25% | 164.88% | 125.20% | 30.08% |
| Income Tax Expenses | 131.82% | 35.60% | 32.26% | 83.08% | 19.38% |
| Earnings from Continuing Operations | 157.28% | 168.13% | 163.83% | 124.39% | 29.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 157.28% | 168.13% | 163.83% | 124.39% | 29.91% |
| EBIT | 161.71% | 171.37% | 166.80% | 127.26% | 31.88% |
| EBITDA | 188.16% | 197.88% | 194.61% | 146.40% | 36.13% |
| EPS Basic | 156.86% | 165.81% | 156.49% | 118.32% | 46.83% |
| Normalized Basic EPS | 158.51% | 166.86% | 157.42% | 118.96% | 46.93% |
| EPS Diluted | 155.25% | 164.31% | 155.17% | 117.51% | 46.45% |
| Normalized Diluted EPS | 158.29% | 166.67% | 157.24% | 118.87% | 46.93% |
| Average Basic Shares Outstanding | 5.37% | 3.98% | 7.62% | 13.92% | 26.28% |
| Average Diluted Shares Outstanding | 5.57% | 4.18% | 7.84% | 13.96% | 26.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |